Clinicians should screen for history of pancreatitis, severe gastrointestinal disease (particularly severe gastroparesis), diabetic retinopathy (particularly if intensifying glycemic control rapidly), and gallbladder disease, as these conditions may influence treatment decisions or require closer monitoring
Workers are loading large pallets of supplies onto C-130 aircraft for delivery
Injection pens need only be refrigerated prior to their first use (check the guidance available for each medication, as room temperature storage guidelines vary)
Clin Mol Hepatol 2024;30:649-652
Table of Contents How Retatrutide Works in the Body Retatrutide is a triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, reducing appetite, improving insulin secretion, and potentially increasing energy expenditure and fat breakdown